Base Genomics

Base Genomics has developed the world’s leading DNA methylation technology, a breakthrough approach for early cancer detection through blood tests

Healthcare & Digital Health

Sector

Seed

Stage

B2B SaaS

Model

01Company Overview

Base Genomics has developed the world’s leading DNA methylation technology, a breakthrough approach for early cancer detection through blood tests.

02Backed By1 investor

03Recent Activity

Portfolio company Base Genomics was acquired by Exact Sciences for $410m.

EXIT·oxfordscienceenterprises.com

OCT 27, 2020

04Similar Companies

E

SG

SB

AI

E

05Startup DNA

8

signals

Sectors
Business Model
Technology